A significant breakthrough in cancer research is emerging with the use of mini-antibodies to re-engage damaged p53. This essential malignant suppressor protein is frequently inactivated in various forms of tumors, https://freshbookmarking.com/story21950930/vhh-fragments-reactivate-the-p53-protein-the-potential-pathway-for-tumor-treatment